About
Small Molecule
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (19)
View allTotal Trials
19
As Lead Sponsor
19
As Collaborator
0
Total Enrollment
14,333
By Phase
PHASE3: 6PHASE2: 7PHASE1: 6
By Status
COMPLETED: 13RECRUITING: 3ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline19 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07219602Lead Sponsor
A Randomized Phase 3 Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
PHASE3Not yet recruiting
300 participants
Started: Dec 31, 2025 · Completed: Jun 30, 2028
NCT06982508Lead Sponsor
Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of Healthy Volunteers
PHASE2Recruiting
100 participants
Started: Sep 9, 2025 · Completed: Dec 31, 2026
NCT06496243Lead Sponsor
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
PHASE2Recruiting
69 participants
Started: Dec 2, 2024 · Completed: Feb 28, 2026
NCT06547359Lead Sponsor
A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects
PHASE1Completed
94 participants
Started: Oct 1, 2024 · Completed: Nov 12, 2024
NCT06305559Lead Sponsor
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
PHASE3Recruiting
300 participants
Started: May 16, 2024 · Completed: Mar 31, 2027
Locations (1)
Headquarters
Naarden, Netherlands
Map
Loading map...